{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T19:21:40Z","timestamp":1747509700345,"version":"3.37.3"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,8,28]],"date-time":"2017-08-28T00:00:00Z","timestamp":1503878400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,8,28]],"date-time":"2017-08-28T00:00:00Z","timestamp":1503878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["16bk0104011h0004"],"award-info":[{"award-number":["16bk0104011h0004"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["In Vitro Cell.Dev.Biol.-Animal"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s11626-017-0192-8","type":"journal-article","created":{"date-parts":[[2017,8,28]],"date-time":"2017-08-28T18:37:17Z","timestamp":1503945437000},"page":"841-851","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Thalidomide induces apoptosis in undifferentiated human induced pluripotent stem cells"],"prefix":"10.1007","volume":"53","author":[{"given":"Saoko","family":"Tachikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshinobu","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromitsu","family":"Nakauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2272-3643","authenticated-orcid":false,"given":"Kiyoshi","family":"Ohnuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,28]]},"reference":[{"key":"192_CR1","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1254\/jphs.13162FP","volume":"124","author":"N Aikawa","year":"2014","unstructured":"Aikawa N, Kunisato A, Nagao K, Kusaka H, Takaba K, Ohgami K (2014) Detection of thalidomide embryotoxicity by in vitro embryotoxicity testing based on human iPS cells. J Pharmacol Sci 124:201\u2013207","journal-title":"J Pharmacol Sci"},{"key":"192_CR2","doi-asserted-by":"publisher","first-page":"E1212","DOI":"10.1073\/pnas.1303094110","volume":"110","author":"M Amita","year":"2013","unstructured":"Amita M, Adachi K, Alexenko AP, Sinha S, Schust DJ, Schulz LC, Roberts RM, Ezashi T (2013) Complete and unidirectional conversion of human embryonic stem cells to trophoblast by BMP4. Proc Natl Acad Sci U S A 110:E1212\u2013E1221","journal-title":"Proc Natl Acad Sci U S A"},{"key":"192_CR3","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.stemcr.2015.07.011","volume":"5","author":"M Ando","year":"2015","unstructured":"Ando M, Nishimura T, Yamazaki S, Yamaguchi T, Kawana-Tachikawa A, Hayama T, Nakauchi Y, Ando J, Ota Y, Takahashi S, Nishimura K, Ohtaka M, Nakanishi M, Miles JJ, Burrows SR, Brenner MK, Nakauchi H (2015) A safeguard system for induced pluripotent stem cell-derived rejuvenated T cell therapy. Stem Cell Rep 5:597\u2013608","journal-title":"Stem Cell Rep"},{"key":"192_CR4","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/nmeth.1593","volume":"8","author":"G Chen","year":"2011","unstructured":"Chen G, Gulbranson DR, Hou Z, Bolin JM, Ruotti V, Probasco MD, Smuga-Otto K, Howden SE, Diol NR, Propson NE, Wagner R, Lee GO, Antosiewicz-Bourget J, Teng JM, Thomson JA (2011) Chemically defined conditions for human iPSC derivation and culture. Nat Methods 8:424\u2013429","journal-title":"Nat Methods"},{"key":"192_CR5","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1038\/1991204a0","volume":"199","author":"CA Debock","year":"1963","unstructured":"Debock CA, Peters A (1963) Effect of thalidomide on the development of the chick embryo. Nature 199:1204\u20131206","journal-title":"Nature"},{"key":"192_CR6","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1016\/S0140-6736(04)16308-3","volume":"363","author":"ME Franks","year":"2004","unstructured":"Franks ME, Macpherson GR, Figg WD (2004) Thalidomide. Lancet 363:1802\u20131811","journal-title":"Lancet"},{"key":"192_CR7","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/0041-008X(65)90095-5","volume":"7","author":"ID Fratta","year":"1965","unstructured":"Fratta ID, Sigg EB, Maiorana K (1965) Teratogenic effects of thalidomide in rabbits, rats, hamsters, and mice. Toxicol Appl Pharmacol 7:268\u2013286","journal-title":"Toxicol Appl Pharmacol"},{"key":"192_CR8","doi-asserted-by":"publisher","first-page":"13409","DOI":"10.1073\/pnas.0806136105","volume":"105","author":"MK Furue","year":"2008","unstructured":"Furue MK, Na J, Jackson JP, Okamoto T, Jones M, Baker D, Hata R, Moore HD, Sato JD, Andrews PW (2008) Heparin promotes the growth of human embryonic stem cells in a defined serum-free medium. Proc Natl Acad Sci U S A 105:13409\u201313414","journal-title":"Proc Natl Acad Sci U S A"},{"key":"192_CR9","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1002\/jcp.24389","volume":"228","author":"CW Guo","year":"2013","unstructured":"Guo CW, Kawakatsu M, Idemitsu M, Urata Y, Goto S, Ono Y, Hamano K, Li TS (2013) Culture under low physiological oxygen conditions improves the stemness and quality of induced pluripotent stem cells. J Cell Physiol 228:2159\u20132166","journal-title":"J Cell Physiol"},{"key":"192_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0014099","volume":"5","author":"Y Hayashi","year":"2010","unstructured":"Hayashi Y, Chan T, Warashina M, Fukuda M, Ariizumi T, Okabayashi K, Takayama N, Otsu M, Eto K, Furue MK, Michiue T, Ohnuma K, Nakauchi H, Asashima M (2010) Reduction of N-glycolylneuraminic acid in human induced pluripotent stem cells generated or cultured under feeder- and serum-free defined conditions. PLoS One 5:e14099","journal-title":"PLoS One"},{"key":"192_CR11","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1002\/pmic.200900758","volume":"10","author":"CS Hughes","year":"2010","unstructured":"Hughes CS, Postovit LM, Lajoie GA (2010) Matrigel: a complex protein mixture required for optimal growth of cell culture. Proteomics 10:1886\u20131890","journal-title":"Proteomics"},{"key":"192_CR12","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1126\/science.1177319","volume":"327","author":"T Ito","year":"2010","unstructured":"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H (2010) Identification of a primary target of thalidomide teratogenicity. Science (New York, NY) 327:1345\u20131350","journal-title":"Science (New York, NY)"},{"key":"192_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010706","volume":"5","author":"SA Jackson","year":"2010","unstructured":"Jackson SA, Schiesser J, Stanley EG, Elefanty AG (2010) Differentiating embryonic stem cells pass through 'temporal windows' that mark responsiveness to exogenous and paracrine mesendoderm inducing signals. PLoS One 5:e10706","journal-title":"PLoS One"},{"key":"192_CR14","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/toxsci\/kft239","volume":"137","author":"S Kameoka","year":"2014","unstructured":"Kameoka S, Babiarz J, Kolaja K, Chiao E (2014) A high-throughput screen for teratogens using human pluripotent stem cells. Toxicol Sci : Off J Soc Toxicol 137:76\u201390","journal-title":"Toxicol Sci : Off J Soc Toxicol"},{"key":"192_CR15","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.4161\/cc.7.9.5793","volume":"7","author":"J Knobloch","year":"2008","unstructured":"Knobloch J, Ruther U (2008) Shedding light on an old mystery: thalidomide suppresses survival pathways to induce limb defects. Cell Cycle 7:1121\u20131127","journal-title":"Cell Cycle"},{"key":"192_CR16","doi-asserted-by":"crossref","unstructured":"Knobloch J, Shaughnessy JD, Ruther U (2007) Thalidomide induces limb deformities by perturbing the Bmp\/Dkk1\/Wnt signaling pathway. FASEB J 21(7):1410\u20131421","DOI":"10.1096\/fj.06-7603com"},{"key":"192_CR17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.5966\/sctm.2015-0145","volume":"5","author":"A Kumagai","year":"2016","unstructured":"Kumagai A, Suga M, Yanagihara K, Itoh Y, Takemori H, Furue MK (2016) A simple method for labeling human embryonic stem cells destined to lose undifferentiated potency. Stem Cells Transl Med 5:275\u2013281","journal-title":"Stem Cells Transl Med"},{"key":"192_CR18","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1111\/j.1582-4934.2010.01105.x","volume":"15","author":"Y Mayshar","year":"2011","unstructured":"Mayshar Y, Yanuka O, Benvenisty N (2011) Teratogen screening using transcriptome profiling of differentiating human embryonic stem cells. J Cell Mol Med 15:1393\u20131401","journal-title":"J Cell Mol Med"},{"key":"192_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044228","volume":"7","author":"K Meganathan","year":"2012","unstructured":"Meganathan K, Jagtap S, Wagh V, Winkler J, Gaspar JA, Hildebrand D, Trusch M, Lehmann K, Hescheler J, Schluter H, Sachinidis A (2012) Identification of thalidomide-specific transcriptomics and proteomics signatures during differentiation of human embryonic stem cells. PLoS One 7:e44228","journal-title":"PLoS One"},{"key":"192_CR20","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.biocel.2007.01.022","volume":"39","author":"M Melchert","year":"2007","unstructured":"Melchert M, List A (2007) The thalidomide saga. Int J Biochem Cell Biol 39:1489\u20131499","journal-title":"Int J Biochem Cell Biol"},{"key":"192_CR21","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/(SICI)1096-9926(199911)60:5<306::AID-TERA11>3.0.CO;2-Y","volume":"60","author":"MT Miller","year":"1999","unstructured":"Miller MT, Stromland K (1999) Teratogen update: thalidomide: a review, with a focus on ocular findings and new potential uses. Teratology 60:306\u2013321","journal-title":"Teratology"},{"key":"192_CR22","unstructured":"Moore KL, Persaud TVN, Torchia MG (2015) The developing human Clinically oriented embryology, 10th edition. Elsevier Health Sciences, Netherlands Amsterdam"},{"key":"192_CR23","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.stem.2009.05.015","volume":"4","author":"J Nichols","year":"2009","unstructured":"Nichols J, Smith A (2009) Naive and primed pluripotent states. Cell Stem Cell 4:487\u2013492","journal-title":"Cell Stem Cell"},{"key":"192_CR24","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.stem.2012.11.002","volume":"12","author":"T Nishimura","year":"2013","unstructured":"Nishimura T, Kaneko S, Kawana-Tachikawa A, Tajima Y, Goto H, Zhu D, Nakayama-Hosoya K, Iriguchi S, Uemura Y, Shimizu T, Takayama N, Yamada D, Nishimura K, Ohtaka M, Watanabe N, Takahashi S, Iwamoto A, Koseki H, Nakanishi M, Eto K, Nakauchi H (2013) Generation of rejuvenated antigen-specific T cells by reprogramming to pluripotency and redifferentiation. Cell Stem Cell 12:114\u2013126","journal-title":"Cell Stem Cell"},{"key":"192_CR25","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/BF00338341","volume":"1","author":"E Nowack","year":"1965","unstructured":"Nowack E (1965) The sensitive phase in thalidomide embryopathy. Humangenetik 1:516\u2013536","journal-title":"Humangenetik"},{"key":"192_CR26","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.stem.2010.06.018","volume":"7","author":"M Ohgushi","year":"2010","unstructured":"Ohgushi M, Matsumura M, Eiraku M, Murakami K, Aramaki T, Nishiyama A, Muguruma K, Nakano T, Suga H, Ueno M, Ishizaki T, Suemori H, Narumiya S, Niwa H, Sasai Y (2010) Molecular pathway and cell state responsible for dissociation-induced apoptosis in human pluripotent stem cells. Cell Stem Cell 7:225\u2013239","journal-title":"Cell Stem Cell"},{"key":"192_CR27","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.1038\/srep04646","volume":"4","author":"K Ohnuma","year":"2014","unstructured":"Ohnuma K, Fujiki A, Yanagihara K, Tachikawa S, Hayashi Y, Ito Y, Onuma Y, Chan T, Michiue T, Furue MK, Asashima M (2014) Enzyme-free passage of human pluripotent stem cells by controlling divalent cations. Sci Rep 4:4646","journal-title":"Sci Rep"},{"key":"192_CR28","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1084\/jem.145.1.204","volume":"145","author":"RW Orkin","year":"1977","unstructured":"Orkin RW, Gehron P, McGoodwin EB, Martin GR, Valentine T, Swarm R (1977) A murine tumor producing a matrix of basement membrane. J Exp Med 145:204\u2013220","journal-title":"J Exp Med"},{"key":"192_CR29","doi-asserted-by":"crossref","unstructured":"Parman T, Wiley MJ, Wells PG (1999) Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity. Nat Med 5:582\u2013585","DOI":"10.1038\/8466"},{"key":"192_CR30","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.neuro.2012.08.016","volume":"33","author":"XY Qin","year":"2012","unstructured":"Qin XY, Akanuma H, Wei F, Nagano R, Zeng Q, Imanishi S, Ohsako S, Yoshinaga J, Yonemoto J, Tanokura M, Sone H (2012) Effect of low-dose thalidomide on dopaminergic neuronal differentiation of human neural progenitor cells: a combined study of metabolomics and morphological analysis. Neurotoxicology 33:1375\u20131380","journal-title":"Neurotoxicology"},{"key":"192_CR31","doi-asserted-by":"crossref","unstructured":"Schardein JL (2000) Chemically induced birth defects, third edition. Informa Healthcare, New York London","DOI":"10.3109\/9780203909904"},{"key":"192_CR32","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1038\/nprot.2011.348","volume":"6","author":"AE Seiler","year":"2011","unstructured":"Seiler AE, Spielmann H (2011) The validated embryonic stem cell test to predict embryotoxicity in vitro. Nat Protoc 6:961\u2013978","journal-title":"Nat Protoc"},{"key":"192_CR33","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/cpt196563303","volume":"6","author":"J Sheskin","year":"1965","unstructured":"Sheskin J (1965) Thalidomide in the treatment of LEPRA reactions. Clin Pharmacol Ther 6:303\u2013306","journal-title":"Clin Pharmacol Ther"},{"key":"192_CR34","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1056\/NEJM199911183412102","volume":"341","author":"S Singhal","year":"1999","unstructured":"Singhal S, Mehta J, Desikan R, Ayers D, Roberson P, Eddlemon P, Munshi N, Anaissie E, Wilson C, Dhodapkar M, Zeddis J, Barlogie B (1999) Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med 341:1565\u20131571","journal-title":"N Engl J Med"},{"key":"192_CR35","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2165\/00003088-200443080-00001","volume":"43","author":"MR Syme","year":"2004","unstructured":"Syme MR, Paxton JW, Keelan JA (2004) Drug transfer and metabolism by the human placenta. Clin Pharmacokinet 43:487\u2013514","journal-title":"Clin Pharmacokinet"},{"key":"192_CR36","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861\u2013872","journal-title":"Cell"},{"key":"192_CR37","doi-asserted-by":"publisher","first-page":"8573","DOI":"10.1073\/pnas.0901505106","volume":"106","author":"C Therapontos","year":"2009","unstructured":"Therapontos C, Erskine L, Gardner ER, Figg WD, Vargesson N (2009) Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation. Proc Natl Acad Sci U S A 106:8573\u20138578","journal-title":"Proc Natl Acad Sci U S A"},{"key":"192_CR38","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","volume":"282","author":"JA Thomson","year":"1998","unstructured":"Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM (1998) Embryonic stem cell lines derived from human blastocysts. Science (New York, NY) 282:1145\u20131147","journal-title":"Science (New York, NY)"},{"key":"192_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0014-4827(92)90397-Q","volume":"202","author":"S Vukicevic","year":"1992","unstructured":"Vukicevic S, Kleinman HK, Luyten FP, Roberts AB, Roche NS, Reddi AH (1992) Identification of multiple active growth factors in basement membrane Matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components. Exp Cell Res 202:1\u20138","journal-title":"Exp Cell Res"},{"key":"192_CR40","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/nbt1310","volume":"25","author":"K Watanabe","year":"2007","unstructured":"Watanabe K, Ueno M, Kamiya D, Nishiyama A, Matsumura M, Wataya T, Takahashi JB, Nishikawa S, Nishikawa S, Muguruma K, Sasai Y (2007) A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol 25:681\u2013686","journal-title":"Nat Biotechnol"},{"key":"192_CR41","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/nbt761","volume":"20","author":"RH Xu","year":"2002","unstructured":"Xu RH, Chen X, Li DS, Li R, Addicks GC, Glennon C, Zwaka TP, Thomson JA (2002) BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nat Biotechnol 20:1261\u20131264","journal-title":"Nat Biotechnol"},{"key":"192_CR42","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.stem.2009.08.001","volume":"5","author":"Y Yoshida","year":"2009","unstructured":"Yoshida Y, Takahashi K, Okita K, Ichisaka T, Yamanaka S (2009) Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell 5:237\u2013241","journal-title":"Cell Stem Cell"},{"key":"192_CR43","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1126\/science.1151526","volume":"318","author":"J Yu","year":"2007","unstructured":"Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science (New York, NY) 318:1917\u20131920","journal-title":"Science (New York, NY)"},{"key":"192_CR44","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0149-2918(00)88289-2","volume":"21","author":"JB Zeldis","year":"1999","unstructured":"Zeldis JB, Williams BA, Thomas SD, Elsayed ME (1999) S.T.E.P.S.: a comprehensive program for controlling and monitoring access to thalidomide. Clin Ther 21:319\u2013330","journal-title":"Clin Ther"}],"container-title":["In Vitro Cellular &amp; Developmental Biology - Animal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11626-017-0192-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11626-017-0192-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11626-017-0192-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T16:10:36Z","timestamp":1589731836000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11626-017-0192-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,28]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["192"],"URL":"https:\/\/doi.org\/10.1007\/s11626-017-0192-8","relation":{},"ISSN":["1071-2690","1543-706X"],"issn-type":[{"type":"print","value":"1071-2690"},{"type":"electronic","value":"1543-706X"}],"subject":[],"published":{"date-parts":[[2017,8,28]]},"assertion":[{"value":"6 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}